NCT00262210View on ClinicalTrials.gov

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 1995

Study Completion Date

December 31, 1999

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Cyclophosphamide Epirubicin Etoposide Prednisolone

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Health Research Institutes, Taiwan

OTHER

NCT00262210 - A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | Biotech Hunter | Biotech Hunter